109 related articles for article (PubMed ID: 10405318)
1. The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells.
Oberle S; Schwartz P; Abate A; Schröder H
Biochem Biophys Res Commun; 1999 Jul; 261(1):28-34. PubMed ID: 10405318
[TBL] [Abstract][Full Text] [Related]
2. [Therapy with NO donors-antiatherogenic and antioxidant actions].
Grosser N; Schröder H
Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
[TBL] [Abstract][Full Text] [Related]
3. Pentaerithrityl tetranitrate and its phase I metabolites are potent activators of cellular cyclic GMP accumulation.
Hinz B; Kuntze U; Schröder H
Biochem Biophys Res Commun; 1998 Dec; 253(3):658-61. PubMed ID: 9918783
[TBL] [Abstract][Full Text] [Related]
4. Endothelial protection by pentaerithrityl trinitrate: bilirubin and carbon monoxide as possible mediators.
Oberle S; Abate A; Grosser N; Hemmerle A; Vreman HJ; Dennery PA; Schneider HT; Stalleicken D; Schröder H
Exp Biol Med (Maywood); 2003 May; 228(5):529-34. PubMed ID: 12709581
[TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase-1 induction may explain the antioxidant profile of pentaerythrityl trinitrate.
Oberle S; Abate A; Grosser N; Vreman HJ; Dennery PA; Schneider HT; Stalleicken D; Schröder H
Biochem Biophys Res Commun; 2002 Feb; 290(5):1539-44. PubMed ID: 11820797
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress.
Thum T; Fraccarollo D; Thum S; Schultheiss M; Daiber A; Wenzel P; Munzel T; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):748-54. PubMed ID: 17255540
[TBL] [Abstract][Full Text] [Related]
7. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J
J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
[TBL] [Abstract][Full Text] [Related]
8. Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.
Schuhmacher S; Oelze M; Bollmann F; Kleinert H; Otto C; Heeren T; Steven S; Hausding M; Knorr M; Pautz A; Reifenberg K; Schulz E; Gori T; Wenzel P; Münzel T; Daiber A
Diabetes; 2011 Oct; 60(10):2608-16. PubMed ID: 21844097
[TBL] [Abstract][Full Text] [Related]
9. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
Kotikoski H; Kankuri E; Vapaatalo H
Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230
[TBL] [Abstract][Full Text] [Related]
10. Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion.
Dragoni S; Gori T; Lisi M; Di Stolfo G; Pautz A; Kleinert H; Parker JD
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1955-9. PubMed ID: 17641250
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the antioxidant properties of pentaerithrityl tetranitrate (PETN)-induction of the intrinsic antioxidative system heme oxygenase-1 (HO-1).
Daiber A; Münzel T
Methods Mol Biol; 2010; 594():311-26. PubMed ID: 20072927
[TBL] [Abstract][Full Text] [Related]
12. A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate.
Grosser N; Schröder H
Biochem Biophys Res Commun; 2000 Jul; 274(1):255-8. PubMed ID: 10903927
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase.
Oppermann M; Dao VT; Suvorava T; Bas M; Kojda G
Br J Pharmacol; 2008 Oct; 155(3):335-42. PubMed ID: 18587420
[TBL] [Abstract][Full Text] [Related]
14. Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production.
Kojda G; Hacker A; Noack E
Eur J Pharmacol; 1998 Aug; 355(1):23-31. PubMed ID: 9754935
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits.
Kojda G; Stein D; Kottenberg E; Schnaith EM; Noack E
J Cardiovasc Pharmacol; 1995 May; 25(5):763-73. PubMed ID: 7543171
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
Daiber A; Oelze M; Coldewey M; Bachschmid M; Wenzel P; Sydow K; Wendt M; Kleschyov AL; Stalleicken D; Ullrich V; Mülsch A; Münzel T
Mol Pharmacol; 2004 Dec; 66(6):1372-82. PubMed ID: 15331769
[TBL] [Abstract][Full Text] [Related]
17. Nitrate tolerance is specific for nitric acid esters and its recovery requires an intact protein synthesis.
Hinz B; Schröder H
Biochem Biophys Res Commun; 1998 Nov; 252(1):232-5. PubMed ID: 9813175
[TBL] [Abstract][Full Text] [Related]
18. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance.
Dikalov S; Fink B; Skatchkov M; Stalleicken D; Bassenge E
J Pharmacol Exp Ther; 1998 Aug; 286(2):938-44. PubMed ID: 9694953
[TBL] [Abstract][Full Text] [Related]
19. The effect of nitric oxide on the production of cyclic AMP by a human osteoblast (HOS) cell line stimulated with hydroxyapatite.
Sosroseno W; Sugiatno E; Samsudin AR; Ibrahim MF
Biomed Pharmacother; 2008 Jun; 62(5):328-32. PubMed ID: 17988826
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
